Massachusetts Financial Services Co. MA reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 20.7% in the 2nd quarter, Holdings Channel.com reports. The fund owned 10,010,867 shares of the medical research company’s stock after selling 2,613,223 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Agilent Technologies were worth $1,362,298,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at about $26,000. SHP Wealth Management acquired a new position in Agilent Technologies in the fourth quarter worth about $26,000. Navalign LLC acquired a new position in Agilent Technologies in the fourth quarter worth about $27,000. Cedar Mountain Advisors LLC bought a new stake in Agilent Technologies in the first quarter valued at about $27,000. Finally, MV Capital Management Inc. bought a new stake in Agilent Technologies in the fourth quarter valued at about $28,000.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. TD Cowen boosted their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Finally, Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $160.24.
Agilent Technologies Price Performance
A opened at $148.55 on Friday. The firm has a market cap of $41.95 billion, a price-to-earnings ratio of 29.83, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The company’s 50-day moving average price is $135.38 and its 200 day moving average price is $125.56. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.
Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
